These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19410556)

  • 21. Cytotoxic T lymphocyte priming versus cytotoxic T lymphocyte tolerance induction: a delicate balancing act involving dendritic cells.
    Melief CJ; Schoenberger S; Toes R; Offringa R
    Haematologica; 1999 Jun; 84 Suppl EHA-4():26-7. PubMed ID: 10907460
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
    Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
    Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tropical theileriosis: cytotoxic T lymphocyte response to vaccination.
    Seitzer U; Ahmed J
    Vaccine; 2008 Dec; 26 Suppl 6():G24-8. PubMed ID: 19178889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma.
    Cao DY; Yang JY; Yue SQ; Tao KS; Song ZS; Wang DS; Yang YL; Dou KF
    Cell Immunol; 2009; 259(1):13-20. PubMed ID: 19545862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No significant CTL cross-priming by dendritic cell-derived exosomes during murine lymphocytic choriomeningitis virus infection.
    Coppieters K; Barral AM; Juedes A; Wolfe T; Rodrigo E; Théry C; Amigorena S; von Herrath MG
    J Immunol; 2009 Feb; 182(4):2213-20. PubMed ID: 19201875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
    J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes.
    Severino ME; Sipsas NV; Nguyen PT; Kalams SA; Walker BD; Johnson RP; Yang OO
    J Virol; 2000 Jul; 74(14):6695-9. PubMed ID: 10864688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans.
    Hashimoto-Okada M; Kitawaki T; Kadowaki N; Iwata S; Morimoto C; Hori T; Uchiyama T
    Int Immunol; 2009 Aug; 21(8):891-904. PubMed ID: 19556308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34+ hematopoietic cells.
    Van Coppernolle S; Verstichel G; Timmermans F; Velghe I; Vermijlen D; De Smedt M; Leclercq G; Plum J; Taghon T; Vandekerckhove B; Kerre T
    J Immunol; 2009 Oct; 183(8):4859-70. PubMed ID: 19801512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A key ingredient for priming killer T cells.
    Barbet G; Blander JM
    Science; 2018 Nov; 362(6415):641-642. PubMed ID: 30409872
    [No Abstract]   [Full Text] [Related]  

  • 32. Requirements for CD8 T-cell migration into the human arterial wall.
    Gewaltig J; Kummer M; Koella C; Cathomas G; Biedermann BC
    Hum Pathol; 2008 Dec; 39(12):1756-62. PubMed ID: 18706675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery.
    Schwab N; Bien CG; Waschbisch A; Becker A; Vince GH; Dornmair K; Wiendl H
    Brain; 2009 May; 132(Pt 5):1236-46. PubMed ID: 19179379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel helper role for CD4 T cells.
    den Haan JM; Bevan MJ
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):12950-2. PubMed ID: 11087850
    [No Abstract]   [Full Text] [Related]  

  • 35. Does programmed CTL proliferation optimize virus control?
    Wodarz D; Thomsen AR
    Trends Immunol; 2005 Jun; 26(6):305-10. PubMed ID: 15922946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A little learning is a dangerous thing; especially for a cytotoxic T-lymphocyte.
    Griffiths PD
    Rev Med Virol; 2003; 13(5):275-6. PubMed ID: 12931338
    [No Abstract]   [Full Text] [Related]  

  • 37. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes.
    Kim S; Shen T; Min B
    J Immunol; 2009 Sep; 183(5):3033-9. PubMed ID: 19667092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The physiological role of cytotoxic CD4(+) T-cells: the holy grail?
    Appay V
    Clin Exp Immunol; 2004 Oct; 138(1):10-3. PubMed ID: 15373899
    [No Abstract]   [Full Text] [Related]  

  • 39. Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy.
    Moldenhauer LM; Diener KR; Thring DM; Brown MP; Hayball JD; Robertson SA
    J Immunol; 2009 Jun; 182(12):8080-93. PubMed ID: 19494334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.